leukoencephalopathy

Its joint venture partner on Tysabri, U. S.-based Biogen Idec, suspended Tysabri in the U.S. in 2005 after two patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.

Drug Maker Elan Swings to Loss Sten Stovall 2010

A Biogen spokeswoman said the company worked with the Food and Drug Administration on the change, which includes a table that details the incidence of progressive multifocal leukoencephalopathy, or PML.

Biogen, Elan's Tysabri Label Updated Thomas Gryta 2011

Some patients taking the drug developed a rare infection—progressive multifocal leukoencephalopathy, or PML—and two patients died.

The Autoimmune Epidemic Donna Jackson Nakazawa 2008

Some patients taking the drug developed a rare infection—progressive multifocal leukoencephalopathy, or PML—and two patients died.

The Autoimmune Epidemic Donna Jackson Nakazawa 2008

But the agency said it was concerned with two serious side effects seen in clinical studies, one being post-transplant lymphoproliferative disorder — a type of lymphoma associated with organ-transplant patients — and a brain infection known as progressive multifocal leukoencephalopathy, or PML, that was seen in one patient in the kidney studies and another patient in an ongoing liver-transplant study.

Drug to Help Transplants Wins Support Jennifer Corbett Dooren 2010

Elan and its joint venture partner on Tysabri, U. S.-based Biogen Idec Inc., suspended Tysabri in the U.S. in 2005 after two patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.

Drug Maker Elan Narrows Loss 2010

Elan and Biogen suspended Tysabri in the U.S. in 2005 after two MS patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.

Elan Considers EDT Spinoff 2010

But the agency said it was concerned with two serious side effects seen in clinical studies, one being post-transplant lymphoproliferative disorder — a type of lymphoma associated with organ-transplant patients — and a brain infection known as progressive multifocal leukoencephalopathy, or PML, that was seen in one patient in the kidney studies and another patient in an ongoing liver-transplant study.

Drug to Help Transplants Wins Support Jennifer Corbett Dooren 2010

Four confirmed or suspected cases of the infection, called progressive multifocal leukoencephalopathy (PML), have been linked to the drug since it was approved for adults with moderate to severe chronic  psoriasis in 2003.

FDA issues advisory for psoriasis drug Raptiva 2009

Now comes word that Genentech is voluntarily recalling the drug because of the risk of the rare brain infection called progressive multifocal leukoencephalopathy (PML).

Psoriasis drug Raptiva recalled 2009